Mindray Resona R9 Financing

Lenders assess collateral based on secondary market liquidity and resale value. Mindray has built a significant installed base, and the R9's secondary market has deepened as more units have entered the used equipment pool. Lenders familiar with medical imaging equipment treat it as a legitimate asset class. The key variables are the system's age, condition, and probe configuration, not the manufacturer's country of origin.

Yes. A $1 buyout lease gives you lease-form documentation with ownership certainty at term end. It is economically equivalent to a term loan but structured as a lease. Some practices prefer it for internal approval processes or accounting treatment. The tax treatment is similar to a loan (the asset typically appears on your balance sheet), but your accountant should confirm the specifics for your practice.

We can finance the new R9 transaction independently of your existing ME8 obligation. Consolidating two active contracts is possible but adds complexity to the deal structure. Most practices find it simpler to let the ME8 loan run its course and finance the R9 separately. If your ME8 has been paid off and holds equity, a sale-leaseback on it is another option to raise cash toward the R9 purchase.

Once the credit decision comes back, we work with you and the dealer on documentation and wire timing. The process from approval to funded typically takes three to five business days. If the dealer has the unit in stock, delivery can often align with funding. Dealers who need a purchase order before reserving a unit can receive one from us upon approval.

The application is the same. The underwriting adds a step to confirm the unit's condition and serial number, but the credit evaluation process is identical. Used transactions sometimes close slightly faster because the equipment is already physically available and there is no manufacturing lead time to account for.